PRKDC and non-small cell lung carcinoma: It has been demonstrated that the anti-apoptotic protein nucleolin (C23) can enhance radiosensitivity in non-small cell lung cancer (NSCLC) by affecting the activity of DNA-dependent protein kinase (DNA-PK) [34].